Dongdong Lu

Dongdong Lu


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2018 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
XXXiaoru Xin
Xiaoru Xin
MWMengying Wu
Mengying Wu
QMQiuyu Meng
Qiuyu Meng
CWChen Wang
Chen Wang
YLYanan Lu
Yanan Lu
DLDongdong Lu
Dongdong Lu
Long noncoding RNA HULC is highly up-regulation in human hepatocellular carcinoma (HCC). However, the functions of HULC in hepatocarcinogenesis remains unclear. RT-PCR, Western blotting, Chromatin immunoprecipitation (CHIP) assay, RNA Immunoprecipitation (RIP) and tumorignesis test in vitro and in vivo were performed. HULC is negatively associated with expression of PTEN or miR15a in patients of human liver cancer. Moreover, HULC accelerates malignant progression of liver cancer cells in vitro and in vivo. Mechanistically, HULC increasesthe expression of P62 via decreasing mature miR15a. On the other hand, excessive HULC increases the expression of LC3 on the level of transcription and then activates LC3 through Sirt1 (a deacetylase). Notably, HULC enhanced the interplay between LC3 and ATG3. Furthermore, HULC also increases the expression of becline-1(autophagy related gene). Therefore, HULC increases the cellular autophagy by increasing LC3II dependent on Sirt1.Noteworthy, excessive HULC reduces the expression of PTEN, β-catenin and enhances the expression of SAPK/JUNK, PKM2, CDK2, NOTCH1, C-Jun in liver cancer cells. Of significance, our observations also revealed that HULC inhibited PTEN through ubiquitin–proteasome system mediated by autophagy-P62.Ultimately,HULC activates AKT-PI3K-mTOR pathway through inhibiting PTEN in human liver cancer cells. This study elucidates a novel mechanism that lncRNA HULC produces a vital function during hepatocarcinogenesis.

30 June 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
HLHaiyan Li
Haiyan Li
JAJiahui An
Jiahui An
MWMengying Wu
Mengying Wu
QZQidi Zheng
Qidi Zheng
XGXin Gui
Xin Gui
DLDongdong Lu
Dongdong Lu
LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2

15 February 2018 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
QZQidi Zheng
Qidi Zheng
ZLZhuojia Lin
Zhuojia Lin
JXJie Xu
Jie Xu
YLYanan Lu
Yanan Lu
QMQiuyu Meng
Qiuyu Meng
DLDongdong Lu
Dongdong Lu
Maternally expressed gene 3 (MEG3) encodes an lncRNA which is suggested to function as a tumor suppressor and has been showed to involve in a variety of cancers. Herein, our findings demonstrate that MEG3 inhibits the malignant progression of liver cancer cells in vitro and in vivo. Mechanistically, MEG3 promotes the expression and maturition of miR122 which targets PKM2. Therefore, MEG3 decreases the expression and nuclear location of PKM2 dependent on miR122. Furthermore, MEG3 also inhibits CyclinD1 and C-Myc via PKM2 in liver cancer cells. On the other hand, MEG3 promotes β-catenin degradation through ubiquitin–proteasome system dependent on PTEN. Strikingly, MEG3 inhibits β-catenin activity through PKM2 reduction and PTEN increase. Significantly, we also found that excessive β-catenin abrogated the effect of MEG3 in liver cancer. In conclusion, our study for the first time demonstrates that MEG3 acts as a tumor suppressor by negatively regulating the activity of the PKM2 and β-catenin signaling pathway in hepatocarcinogenesis and could provide potential therapeutic targets for the treatment of liver cancer.

10 September 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
HLHaiyan Li
Haiyan Li
JLJiao Li
Jiao Li
SJSong Jia
Song Jia
MWMengying Wu
Mengying Wu
JAJiahui An
Jiahui An
DLDongdong Lu
Dongdong Lu
MiR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer

19 October 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
HPHu Pu
Hu Pu
QZQidi Zheng
Qidi Zheng
HLHaiyan Li
Haiyan Li
MWMengying Wu
Mengying Wu
JAJiahui An
Jiahui An
DLDongdong Lu
Dongdong Lu
CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc

1 December 2015 in Molecular Therapy
Verified
Journal Article
Open access
XGXin Gui
Xin Gui
HLHaiyan Li
Haiyan Li
TLTianming Li
Tianming Li
HPHu Pu
Hu Pu
DLDongdong Lu
Dongdong Lu
Mt is a cross-disciplinary biomedical journal devoted to publishing the most exciting advances in pharmacology and therapeutics, as they pertain to advances in translational and clinical medicine. It is recognized as one of the most prestigious journals in the field. With an impact factor of 6.825*, mt ranks in the top 4.2% of scientific journals in the latest Science Citation Index. Published monthly online and in print.